Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study

The global breakout of COVID-19 and raised death toll has prompted scientists to develop novel drugs capable of inhibiting SARS-CoV-2. Conducting studies on repurposing some FDA-approved glucocorticoids can be a promising prospective for finding a treatment for COVID-19. In addition, the use of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmaaty, Ayman Abo, Alnajjar, Radwan, Hamed, Mohammed I. A., Khattab, Muhammad, Khalifa, Mohamed M., Al-Karmalawy, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695394/
https://www.ncbi.nlm.nih.gov/pubmed/35423530
http://dx.doi.org/10.1039/d0ra10674g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695394/
https://www.ncbi.nlm.nih.gov/pubmed/35423530
http://dx.doi.org/10.1039/d0ra10674g

Ejemplares similares